{
    "2020-07-14": [
        [
            {
                "time": "",
                "original_text": "贝达药业上半年净利润预增55%-75%",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "净利润",
                        "预增",
                        "55%",
                        "75%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：上半年预计净利润同比增长55.0%~75.0%",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "净利润",
                        "同比增长",
                        "55.0%",
                        "75.0%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业(300558.SZ)：凯铭投资解质180万股",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "凯铭投资",
                        "解质",
                        "180万股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：上半年净利同比预增55%-75%",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "净利",
                        "同比预增",
                        "55%",
                        "75%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业(300558.SZ)：上半年净利预增55%-75%",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "净利",
                        "预增",
                        "55%",
                        "75%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}